BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 33744088)

  • 1. Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.
    Nathan SD; Cottin V; Behr J; Hoeper MM; Martinez FJ; Corte TJ; Keogh AM; Leuchte H; Mogulkoc N; Ulrich S; Wuyts WA; Yao Z; Ley-Zaporozhan J; Müller-Lisse UG; Scholle FD; Brüggenwerth G; Busse D; Nikkho S; Wells AU
    J Heart Lung Transplant; 2021 Jun; 40(6):494-503. PubMed ID: 33744088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.
    Nathan SD; Behr J; Collard HR; Cottin V; Hoeper MM; Martinez FJ; Corte TJ; Keogh AM; Leuchte H; Mogulkoc N; Ulrich S; Wuyts WA; Yao Z; Boateng F; Wells AU
    Lancet Respir Med; 2019 Sep; 7(9):780-790. PubMed ID: 31416769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autopsy study of combined pulmonary fibrosis and emphysema: correlations among clinical, radiological, and pathological features.
    Inomata M; Ikushima S; Awano N; Kondoh K; Satake K; Masuo M; Kusunoki Y; Moriya A; Kamiya H; Ando T; Yanagawa N; Kumasaka T; Ogura T; Sakai F; Azuma A; Gemma A; Takemura T
    BMC Pulm Med; 2014 Jun; 14():104. PubMed ID: 24972672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema.
    Minegishi Y; Kokuho N; Miura Y; Matsumoto M; Miyanaga A; Noro R; Saito Y; Seike M; Kubota K; Azuma A; Kida K; Gemma A
    Lung Cancer; 2014 Aug; 85(2):258-63. PubMed ID: 24894326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
    Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
    Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis.
    Zhang L; Zhang C; Dong F; Song Q; Chi F; Liu L; Wang Y; Che C
    BMC Pulm Med; 2016 Nov; 16(1):137. PubMed ID: 27809901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Clinical Phenotypes in Idiopathic Interstitial Pneumonia with Pulmonary Emphysema.
    Sato S; Tanino Y; Misa K; Fukuhara N; Nikaido T; Uematsu M; Fukuhara A; Wang X; Ishida T; Munakata M
    Intern Med; 2016; 55(12):1529-35. PubMed ID: 27301501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated computed tomography quantification of fibrosis predicts prognosis in combined pulmonary fibrosis and emphysema in a real-world setting: a single-centre, retrospective study.
    Nemoto M; Nei Y; Bartholmai B; Yoshida K; Matsui H; Nakashita T; Motojima S; Aoshima M; Ryu JH
    Respir Res; 2020 Oct; 21(1):275. PubMed ID: 33081788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation.
    Takahashi T; Terada Y; Pasque MK; Liu J; Byers DE; Witt CA; Nava RG; Puri V; Kozower BD; Meyers BF; Kreisel D; Patterson GA; Hachem RR
    Chest; 2021 Nov; 160(5):1743-1750. PubMed ID: 34186034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia.
    Wémeau-Stervinou L; Perez T; Murphy C; Polge AS; Wallaert B
    Respir Med; 2012 Apr; 106(4):564-70. PubMed ID: 22221584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in fibrosing idiopathic interstitial pneumonia: Uncertainties, challenges and opportunities.
    Girgis RE; Hoeper MM
    J Heart Lung Transplant; 2021 Sep; 40(9):872-881. PubMed ID: 33832831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-normal lung volume correlates with pulmonary hypertension in fibrotic idiopathic interstitial pneumonia: computer-aided 3D quantitative analysis of chest CT.
    Iwasawa T; Kato S; Ogura T; Kusakawa Y; Iso S; Baba T; Fukui K; Oba MS
    AJR Am J Roentgenol; 2014 Aug; 203(2):W166-73. PubMed ID: 25055292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis.
    Yoon HY; Kim TH; Seo JB; Lee SM; Lim S; Lee HN; Kim N; Han M; Kim DS; Song JW
    Respirology; 2019 Jan; 24(1):55-62. PubMed ID: 30136753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality.
    Champtiaux N; Cottin V; Chassagnon G; Chaigne B; Valeyre D; Nunes H; Hachulla E; Launay D; Crestani B; Cazalets C; Jego P; Bussone G; Bérezné A; Guillevin L; Revel MP; Cordier JF; Mouthon L;
    Semin Arthritis Rheum; 2019 Aug; 49(1):98-104. PubMed ID: 30409416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between quantitative CT metrics and pulmonary function in combined pulmonary fibrosis and emphysema.
    Ando K; Sekiya M; Tobino K; Takahashi K
    Lung; 2013 Dec; 191(6):585-91. PubMed ID: 24085320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.